Liver Transplantation Department, Koc University Hospital, Istanbul, Turkey.
Liver Transplantation Department, Koc University Hospital, Istanbul, Turkey.
Transplant Proc. 2021 Jun;53(5):1622-1625. doi: 10.1016/j.transproceed.2021.03.012. Epub 2021 Apr 21.
Cardiovascular complication is one of the leading causes of mortality after liver transplantation (LT). Thus, a thorough cardiac evaluation is a must before proceeding to a liver transplant surgery. Percutaneous coronary intervention (PCI) with stent and to a lesser extent coronary artery bypass grafting (CABG) are both valuable treatment options for patients with coronary artery disease.
A retrospective, single-center study that included patients who underwent cardiac intervention and subsequent LT for end-stage liver disease. All patients who had PCI or CABG were included in the study.
Twenty-nine adult patients out of 51 had a cardiac intervention before liver transplantation. Twenty-four patients had a diagnostic PCI, 3 patients had therapeutic PCI with stent, and 2 had failed PCI and proceeded to CABG before liver transplant. The mean age of the patients was 60.5 years. There were 24 men. All patients had cirrhosis. The 2 CABG cases were done during the same admission with a 13- and 18-day interval between the CABG and the transplantation. Both cases were live-related liver transplantation. No mortality was reported.
In case of PCI failure, CABG may be a valuable and safe treatment option for cirrhotic patients as a preparation for liver transplantation. Live donor liver transplantation may be a good back-up for those patients in case they develop hepatic decompensation.
心血管并发症是肝移植(LT)后死亡的主要原因之一。因此,在进行肝移植手术前,必须进行彻底的心脏评估。经皮冠状动脉介入治疗(PCI)和支架置入术,以及在较小程度上的冠状动脉旁路移植术(CABG),都是治疗冠心病患者的有价值的治疗选择。
这是一项回顾性、单中心研究,纳入了因终末期肝病而行心脏介入治疗和随后接受 LT 的患者。所有接受 PCI 或 CABG 的患者均纳入研究。
51 例患者中有 29 例在 LT 前进行了心脏介入治疗。24 例患者行诊断性 PCI,3 例患者行支架治疗性 PCI,2 例患者因 PCI 失败而行 CABG,然后进行 LT。患者的平均年龄为 60.5 岁,其中 24 例为男性。所有患者均患有肝硬化。2 例 CABG 手术均在同一住院期间进行,CABG 与移植之间的间隔为 13 天和 18 天。这两个病例均为活体相关肝移植。未报告死亡。
对于 PCI 失败的患者,CABG 可能是肝硬化患者准备 LT 的一种有价值且安全的治疗选择。对于那些可能出现肝失代偿的患者,活体供肝移植可能是一个很好的后备选择。